Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer
590.6500 -6.40 (-1.07%)
NSE May 22, 2025 15:53 PM
Volume: 1.7M
 

logo
Laurus Labs Ltd.
05 Dec 2016
590.65
-1.07%
BP Wealth
Laurus Labs Limited (Laurus Labs) was originally incorporated on September 19, 2005 at Hyderabad, Andhra Pradeshas a Private Limited Company. The company was subsequently converted into a public limited company and its name was changed to Laurus Labs Limited. Laurus Labs Limited (Laurus Labs) is the leading research and development (R&D;) driven pharmaceutical company in India, with a leadership position in Generic Active Pharmaceutical Ingredients (APIs) for select, high-growth Therapeutic areas of Anti-Retrovirals (ARVs) and Hepatitis C. The company also manufacture APIs in Oncology and other Therapeutic areas. The strategic and early investments in R&D; and Manufacturing infrastructure have enabled them to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing Donor-Funded Access-to-Medicines Markets of Sub...
Laurus Labs Ltd. is trading above its 200 day SMA of 539.8
More from Laurus Labs Ltd.
Recommended